Showing results (261-270 of 305) with videos related to

Sort By:
Pageof 31
Journal of the National Cancer Institute|May 6, 2024
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)Elisa Fontana, Ezra Rosen, Elizabeth K Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancersAinhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2024
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancersAinhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2018
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II ConsortiumStephanie Lheureux, Anna Tinker, Blaise Clarke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2023
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trialE Pujade-Lauraine, F Selle, G Scambia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2023
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor ProgressionStephanie Lheureux, Stephenie D Prokopec, Leslie E Oldfield, et al.
Gynecologic Oncology|October 10, 2025
Multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program in patients with advanced gynecological cancers: A prospective studyV Garg, E Armstrong, A Celeste, et al.
Journal for Immunotherapy of Cancer|February 26, 2025
Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancerVladimir Roudko, Diane Marie Del Valle, Emir Radkevich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Genomic and epigenomic ctDNA profiling in liquid biopsies from heavily pre-treated patients with DNA damage response-deficient tumorsIan M Silverman, Joseph D Schonoft, Benjamin Herzberg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 21, 2023
Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods studyCamilla Zimmermann, Ashley Pope, Breffni Hannon, et al.
Pageof 31